ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q3Scopus Q2SCImago #8,980Gold OA

AIDS Research and Treatment

Identifier (ISSN):2090-1240(Print)/2090-1259(Online)
•
Publisher:Hindawi Limited
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
2.1↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for AIDS Research and Treatment

WoS Q3
01231.720231.120241.820252.12026
Annual Impact Factor Metric
Current (2026):2.1
Scopus SJR & RankScopus Q2
0.652
#8,980

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
37

37 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
3articles/year
100% Gold OA•75% Original Research

Aims & Scope

AIDS Research and Treatment is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies focused on all aspects of HIV and AIDS, from the molecular basis of disease to translational and clinical research. In addition, articles relating to prevention, education, and behavior change will be considered

Topics Covered (Recognized by AI)
Medicine99.1%Biology95.1%Family medicine89.2%Immunology88.3%Human immunodeficiency virus (HIV)86.8%Virology86.8%Internal medicine66.8%Pathology54.5%Genetics53.2%Mathematics50.2%Sociology49.5%Virus42.2%Demography41.8%Statistics41.8%Psychology41.5%Viral load38.2%Computer science37.8%Environmental health34.5%Psychiatry33.8%Antiretroviral therapy33.8%Nursing31.4%Political science31.1%Law30.5%Population29.8%Economics29.2%Surgery28%Chemistry21.8%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

INFECTIOUS DISEASES

Q3
Rank95/141
IndexESCI
JCIESCI2026

INFECTIOUS DISEASES

Q3
Rank103/141
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.1
Articles / Year28
Total Citations1
2025
IF1.8
Articles / Year34
Total Citations70
2024
IF1.1
Articles / Year7
Total Citations12
2023
IF1.7
Articles / Year11
Total Citations63
2022
IF—
Articles / Year13
Total Citations113

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,980Scopus Q2SCImago Profile
Scopus Coverage:2010-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.652

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.06

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,009 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations60
3-Year Documents29
Citable Documents29

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate33.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

DermatologyQ2
Infectious DiseasesQ2
Public Health, Environmental and Occupational HealthQ2
Immunology and AllergyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区INFECTIOUS DISEASES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

AIDS Research and Treatment (ISSN: 2090-1240) is a peer-reviewed international scholarly journal in the field of INFECTIOUS DISEASES, published by Hindawi Limited in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 2.10, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.652 (Q2), an H-index of 37.

The journal enforces rigorous peer evaluation with an annual output of approximately 3 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,009 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Hindawi Limited
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: ebc31649-0c05-4ce9-b551-5dd9408ae4e2
Database Updated: 2026-10-01